Biocept (FRA:B00) Other Long Term Assets : €0.36 Mil (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Biocept Other Long Term Assets?

Biocept's other long-term assets for the quarter that ended in Jun. 2023 was €0.36 Mil.

Biocept's quarterly other long-term assets declined from Dec. 2022 (€0.36 Mil) to Mar. 2023 (€0.36 Mil) but then stayed the same from Mar. 2023 (€0.36 Mil) to Jun. 2023 (€0.36 Mil).

Biocept's annual other long-term assets increased from Dec. 2020 (€0.35 Mil) to Dec. 2021 (€0.40 Mil) but then declined from Dec. 2021 (€0.40 Mil) to Dec. 2022 (€0.36 Mil).

Biocept Other Long Term Assets Historical Data

The historical data trend for Biocept's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocept Other Long Term Assets Chart

Biocept Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Long Term Assets

Get a 7-Day Free Trial

0.35

0.40

0.36

Biocept Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Other Long Term Assets	Get a 7-Day Free Trial															0.47	0.40	0.36	0.36	0.36

Biocept Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Biocept (FRA:B00) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biocept Inc (FRA:B00) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

BIOCQ:USA

Address

9955 Mesa Rim Road, San Diego, CA, USA, 92121

Website

https://www.biocept.com

Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.

Biocept (FRA:B00) Headlines

No Headlines